Analyst Consensus ?
ConsensusHold38 ratings
Bullish1847.4%
Neutral1744.7%
Bearish37.9%
1 unmapped firm rating excluded from the percentages.
Camden Property Trust · CPT · FY2026 Q3 · Calendar Q4 2026
Transcript analysis conflicts with CPT event identity
The supplied materials do not support a reliable investment thesis for Camden Property Trust: the event is identified as CPT, while the transcript analysis describes Baytex Energy and oil-and-gas operations.
Why did CPT fall 3.1% after missing EPS estimates in FY2026 Q3?
Research this report with FN2. Free to start; review your question before sending.
Reported After market closeNYSEReal Estate
$10.42B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.17
Consensus $0.23
EPS surprise
-27.2%
Reported versus consensus
Reported revenue
$381.1M
Consensus $384.9M
Revenue surprise
-1.0%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-3.1%
Event window
SPY move
+0.6%
Same window
Abnormal move
-3.7%
Stock minus SPY
Volume
0.7×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
CPTSPY benchmark
Ask FN2 about CPT FY2026 Q3
Choose a question to continue your research
Why did CPT fall 3.1% after missing EPS estimates in FY2026 Q3?What changed in CPT's guidance and outlook in FY2026 Q3?Give me the bull and bear case for CPT after FY2026 Q3 earnings.
Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
The current event is labeled Camden Property Trust (CPT), but the attached transcript analysis concerns Baytex Energy. This identity conflict prevents a valid quarter-over-quarter comparison or CPT earnings interpretation.
Guidance delta
Not assessable for CPT from the supplied analysis; the transcript summary is attributed to a different company.
Key takeaways
- The event metadata identifies Camden Property Trust (CPT).
- The current transcript analysis describes Baytex Energy, including oil production and oilfield projects.
- CPT-specific operating results, guidance changes, and management commentary cannot be established from this material.
Management priorities
- CPT management priorities cannot be established from the supplied analysis.
Follow CPT with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$100.39Current
$98Low
$121.49Average
$193High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 6, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 19, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 19, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 14, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 14, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 13, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Oct 12, 2026 |
| Truist Securities | Buy | Buy | Maintain | Sep 25, 2026 |
| Scotiabank | Sector Underperform | Sector Underperform | Maintain | Sep 17, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Sep 8, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 13, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 12, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Aug 3, 2026 |
| B of A Securities | Buy | Buy | Maintain | Nov 12, 2025 |
| Goldman Sachs | Sell | Neutral | Downgrade | Sep 17, 2025 |
| Stifel | Buy | Hold | Upgrade | Aug 26, 2025 |
| Citigroup | Buy | Buy | Maintain | Aug 14, 2025 |
| Jefferies | Buy | Hold | Upgrade | Mar 10, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Sep 10, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Aug 5, 2024 |
| Baird | Outperform | Outperform | Maintain | Mar 12, 2024 |
| BMO Capital | Market Perform | Outperform | Downgrade | Dec 15, 2023 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | May 15, 2023 |
| Keybanc | Overweight | Downgrade | Feb 22, 2021 | |
| CFRA | Buy | Buy | Maintain | May 8, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 2, 2020 |
| BTIG | Neutral | Buy | Downgrade | Mar 10, 2020 |
| Zelman | Sell | Hold | Downgrade | Feb 4, 2020 |
| Sandler O'Neill | Buy | Hold | Upgrade | Dec 20, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Nov 7, 2019 |
| Capital One Financial | Overweight | Equal Weight | Upgrade | Sep 16, 2019 |
| Capital One | Overweight | Equal Weight | Upgrade | Sep 16, 2019 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Dec 20, 2018 |
| Janney Capital | Buy | Neutral | Upgrade | Dec 20, 2018 |
| BTIG Research | Buy | Neutral | Upgrade | Apr 24, 2017 |
| Mitsubishi UFJ | Neutral | Underweight | Upgrade | Jan 5, 2017 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 29, 2016 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jul 31, 2015 |
| Imperial Capital | Outperform | Outperform | Maintain | May 9, 2014 |
| Macquarie | Neutral | Outperform | Downgrade | Jul 17, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $100.39. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | James Feldman | $103 | $98.59 | +2.6% | Oct 19, 2026 |
| UBS | Analyst unavailable | $101 | $97.46 | +0.6% | Oct 14, 2026 |
| Barclays | Analyst unavailable | $114 | $98 | +13.6% | Oct 14, 2026 |
| Truist Financial | Michael Lewis | $108 | $97.1 | +7.6% | Sep 25, 2026 |
| Evercore ISI | Steve Sakwa | $110 | $98.63 | +9.6% | Sep 21, 2026 |
| UBS | Ami Probandt | $105 | $103.83 | +4.6% | Sep 15, 2026 |
| Mizuho Securities | Analyst unavailable | $116 | $105.69 | +15.5% | Sep 8, 2026 |
| Barclays | Analyst unavailable | $123 | $110.36 | +22.5% | Aug 17, 2026 |
| Morgan Stanley | Analyst unavailable | $118 | $108.29 | +17.5% | Aug 12, 2026 |
| Evercore ISI | Steve Sakwa | $114 | $111.14 | +13.6% | Aug 7, 2026 |
| Stifel Nicolaus | Simon Yarmak | $123.25 | $113.29 | +22.8% | Jul 31, 2026 |
| Wells Fargo | James Feldman | $113 | $112.09 | +12.6% | Jul 22, 2026 |
| Piper Sandler | Analyst unavailable | $119 | $112.86 | +18.5% | Jul 21, 2026 |
| Deutsche Bank | Peter Abramowitz | $114 | $112.86 | +13.6% | Jul 20, 2026 |
| Barclays | Analyst unavailable | $122 | $114.19 | +21.5% | Jul 14, 2026 |
| Scotiabank | Analyst unavailable | $109 | $114 | +8.6% | Jul 9, 2026 |
| Morgan Stanley | Analyst unavailable | $120 | $112.62 | +19.5% | Jun 25, 2026 |
| Scotiabank | Nicholas Yulico | $102 | $110.44 | +1.6% | Jun 18, 2026 |
| Truist Financial | Michael Lewis | $123 | $115.86 | +22.5% | Jun 11, 2026 |
| Evercore ISI | Steve Sakwa | $113 | $112.88 | +12.6% | Jun 8, 2026 |
| Morgan Stanley | Adam Kramer | $117 | $103.47 | +16.5% | May 15, 2026 |
| UBS | Analyst unavailable | $106 | $104.58 | +5.6% | May 14, 2026 |
| Scotiabank | Analyst unavailable | $95 | $105.35 | -5.4% | May 14, 2026 |
| Barclays | Richard Hightower | $116 | $103.77 | +15.5% | May 11, 2026 |
| RBC Capital | Brad Heffern | $105 | $105.68 | +4.6% | May 4, 2026 |
| Cantor Fitzgerald | Richard Anderson | $102 | $104.45 | +1.6% | May 4, 2026 |
| Evercore ISI | Analyst unavailable | $107 | $104.76 | +6.6% | May 1, 2026 |
| Stifel Nicolaus | Analyst unavailable | $118.75 | $105.02 | +18.3% | May 1, 2026 |
| RBC Capital | Analyst unavailable | $108 | $109.37 | +7.6% | Feb 10, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $108 | $107.96 | +7.6% | Feb 9, 2026 |
| Stifel Nicolaus | Analyst unavailable | $118.5 | $106.57 | +18.0% | Feb 6, 2026 |
| Piper Sandler | Analyst unavailable | $108 | $108.02 | +7.6% | Jan 27, 2026 |
| Truist Financial | Michael Lewis | $118 | $109.5 | +17.5% | Jan 20, 2026 |
| Barclays | Richard Hightower | $119 | $106.83 | +18.5% | Jan 13, 2026 |
| Mizuho Securities | Analyst unavailable | $120 | $107.79 | +19.5% | Jan 12, 2026 |
| UBS | Analyst unavailable | $108 | $108.23 | +7.6% | Jan 8, 2026 |
| Truist Financial | Analyst unavailable | $116 | $104.21 | +15.5% | Dec 15, 2025 |
| Wells Fargo | Analyst unavailable | $110 | $106.82 | +9.6% | Nov 25, 2025 |
| Barclays | Richard Hightower | $118 | $104.64 | +17.5% | Nov 25, 2025 |
| Mizuho Securities | Analyst unavailable | $114 | $105.23 | +13.6% | Nov 24, 2025 |
| Cantor Fitzgerald | Richard Anderson | $105 | $101.88 | +4.6% | Nov 10, 2025 |
| Evercore ISI | Analyst unavailable | $108 | $98.31 | +7.6% | Nov 3, 2025 |
| Evercore ISI | Analyst unavailable | $115 | $101.91 | +14.6% | Oct 13, 2025 |
| Wells Fargo | Analyst unavailable | $111 | $101.67 | +10.6% | Oct 13, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $115 | $106.78 | +14.6% | Oct 1, 2025 |
| Barclays | Analyst unavailable | $127 | $106.55 | +26.5% | Sep 30, 2025 |
| Goldman Sachs | Analyst unavailable | $106 | $106.47 | +5.6% | Sep 17, 2025 |
| Stifel Nicolaus | Simon Yarmak | $122.75 | $108.87 | +22.3% | Aug 26, 2025 |
| Scotiabank | Nicholas Yulico | $133 | $106.02 | +32.5% | Aug 14, 2025 |
| RBC Capital | Analyst unavailable | $118 | $105.77 | +17.5% | Aug 4, 2025 |
| Barclays | Richard Hightower | $137 | $112.48 | +36.5% | Jul 15, 2025 |
| Truist Financial | Michael Lewis | $131 | $119.06 | +30.5% | May 19, 2025 |
| Jefferies | Analyst unavailable | $139 | $121.49 | +38.5% | Mar 9, 2025 |
| Jefferies | Linda Tsai | $117 | $116.04 | +16.5% | Jan 1, 2025 |
| Stifel Nicolaus | Simon Yarmak | $121 | $119.33 | +20.5% | Nov 13, 2024 |
| Deutsche Bank | Omotayo Okusanya | $115 | $121.32 | +14.6% | Sep 10, 2024 |
| Evercore ISI | Steve Sakwa | $116 | $122.17 | +15.5% | Sep 9, 2024 |
| Goldman Sachs | Julien Blouin | $139 | $126.6 | +38.5% | Sep 4, 2024 |
| Piper Sandler | Alexander Goldfarb | $128 | $122.9 | +27.5% | Aug 26, 2024 |
| Wells Fargo | James Feldman | $127 | $122.6 | +26.5% | Aug 26, 2024 |
| Truist Financial | Michael Lewis | $133 | $122.4 | +32.5% | Aug 23, 2024 |
| Bank of America Securities | Jeffrey Spector | $147 | $119.54 | +46.4% | Aug 12, 2024 |
| RBC Capital | Brad Heffern | $122 | $114.96 | +21.5% | Aug 5, 2024 |
| Mizuho Securities | Vikram Malhotra | $108 | $99.4 | +7.6% | May 30, 2024 |
| Robert W. Baird | Amanda Sweitzer | $115 | $103.6 | +14.6% | May 28, 2024 |
| Morgan Stanley | Adam Kramer | $105.5 | $106.74 | +5.1% | May 14, 2024 |
| Mizuho Securities | Vikram Malhotra | $111 | $105.08 | +10.6% | May 6, 2024 |
| RBC Capital | Brad Heffern | $110 | $105.08 | +9.6% | May 6, 2024 |
| Piper Sandler | Alexander Goldfarb | $110 | $105.08 | +9.6% | May 6, 2024 |
| Truist Financial | Michael Lewis | $114 | $102.13 | +13.6% | Apr 9, 2024 |
| Truist Financial | Michael Lewis | $113 | $98.19 | +12.6% | Mar 12, 2024 |
| BMO Capital | John Kim | $100 | $94.49 | -0.4% | Feb 21, 2024 |
| Wedbush | Richard Anderson | $98 | $92.7 | -2.4% | Dec 4, 2023 |
| Piper Sandler | Alexander Goldfarb | $194 | $84.63 | +93.2% | Oct 31, 2023 |
| Truist Financial | Michael Lewis | $134 | $108.62 | +33.5% | Aug 8, 2023 |
| Mizuho Securities | Vikram Malhotra | $125 | $113.01 | +24.5% | Jan 10, 2023 |
| UBS | Analyst unavailable | $137 | $116.78 | +36.5% | Dec 15, 2022 |
| Truist Financial | Analyst unavailable | $136 | $117.02 | +35.5% | Nov 29, 2022 |
| Evercore ISI | Analyst unavailable | $147 | $117.32 | +46.4% | Sep 27, 2022 |
| Evercore ISI | Analyst unavailable | $150 | $127.24 | +49.4% | Sep 19, 2022 |
| Mizuho Securities | Analyst unavailable | $136 | $129 | +35.5% | Sep 19, 2022 |
| Barclays | Analyst unavailable | $169 | $130.76 | +68.3% | Sep 15, 2022 |
| Goldman Sachs | Analyst unavailable | $158 | $146.96 | +57.4% | Aug 16, 2022 |
| RBC Capital | Analyst unavailable | $155 | $139.59 | +54.4% | Aug 1, 2022 |
| Piper Sandler | Analyst unavailable | $155 | $133.83 | +54.4% | Jul 20, 2022 |
| Mizuho Securities | Analyst unavailable | $142 | $133.97 | +41.4% | Jun 27, 2022 |
| Truist Financial | Analyst unavailable | $149 | $134.61 | +48.4% | Jun 24, 2022 |
| Robert W. Baird | Analyst unavailable | $153 | $134.61 | +52.4% | Jun 24, 2022 |
| Truist Financial | Analyst unavailable | $160 | $140.28 | +59.4% | May 25, 2022 |
| Scotiabank | Analyst unavailable | $171 | $138.39 | +70.3% | May 19, 2022 |
| Evercore ISI | Richard Hightower | $178 | $165.33 | +77.3% | Feb 4, 2022 |
| BMO Capital | John Kim | $179 | $164.3 | +78.3% | Feb 3, 2022 |
| Barclays | Anthony Powell | $193 | $163.77 | +92.3% | Jan 18, 2022 |
| Wells Fargo | Tammi Fique | $180 | $164.76 | +79.3% | Nov 22, 2021 |
| Bank of America Securities | Jeffrey Spector | $178 | $144.9 | +77.3% | Sep 27, 2021 |
| Goldman Sachs | Chandni Luthra | $172 | $148.71 | +71.3% | Sep 23, 2021 |
| Piper Sandler | Alexander Goldfarb | $178 | $150.1 | +77.3% | Sep 1, 2021 |
Track every rating change on CPT the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCamden Property Trust, an S&P 400 listed entity, specializes in real estate, primarily through the ownership, operation, development, renovation, purchase, and building of multi-family residential complexes. Currently, Camden possesses stakes in and manages 167 properties housing 56,850 apartment units throughout the United States. With seven additional properties presently under construction, the company's total portfolio will expand to 174 properties offering 59,104 apartment homes. Camden has earned consistent recognition for its workplace culture, being named one of FORTUNE magazine's "100 Best Companies to Work For®" for 13 straight years, most recently achieving the #18 spot. Furthermore, in 2020, it secured the #25 position among large U.S. companies in the Glassdoor Employees' Choice Award.
Historical context
All CPT earningsReal Estate peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| VMRK Vivmark Residential | FY2026 Q3 · Calendar Q4 2026 | -425.6% | +2.4% | Vivmark lifts 2026 revenue outlook as merger integration advances |
| IRM Iron Mountain Incorporated | FY2026 Q3 · Calendar Q4 2026 | +4.6% | -11.1% | Iron Mountain’s Q3 growth broadens, while expansion risks remain |
| LAMR Lamar Advertising Company | FY2026 Q3 · Calendar Q4 2026 | -3.6% | -0.8% | Lamar Q3: AFFO Outlook Raised as Digital and Political Demand Support Growth |
Latest beats and misses
Who reports nextBeat on EPS
- EOGFY2026 Q3 · November 5, 2026+8.9% EPS+2.2% move
- PBAFY2026 Q3 · November 5, 2026+13.5% EPS+1.0% move
- FNFFY2026 Q3 · November 5, 20260.0% EPS+6.6% move
- MTDFY2026 Q3 · November 5, 2026+3.6% EPS+4.8% move
- IAGFY2026 Q3 · November 5, 2026+16.7% EPS+4.6% move
- GMABFY2026 Q3 · November 5, 2026+55.6% EPS-4.3% move
Missed on EPS
- WPMFY2026 Q3 · November 5, 2026-1.1% EPS+2.2% move
- VMRKFY2026 Q3 · November 4, 2026-425.6% EPS+2.4% move
- NTRAFY2026 Q3 · November 5, 2026-49.3% EPS-15.2% move
- TIGOFY2026 Q3 · November 5, 2026-40.8% EPS+2.6% move
- UHALFY2027 Q2 · November 4, 2026-15.4% EPS-3.2% move
- LAMRFY2026 Q3 · November 5, 2026-3.6% EPS-0.8% move
Get the CPT recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-06T18:06:45.717175+00:00
- FN2 earnings calendar · 2026-11-06T01:23:16.275024+00:00
- Polygon adjusted daily market bars · 2026-11-06T18:30:48.822006+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-06T18:30:48.819337+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-06. For educational purposes only; not investment advice.